This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES: Oligonucleotide & Peptide Therapeutics Content Hub
24/7 Access
Digital & In-Person
Menu

Hans Kistemaker, PhD
Senior Scientist, Chemistry & Manufacturing at ProQR Therapeutics
Speaker

Profile

Hans Kistemaker obtained his BSc. and MSc. in chemistry from the University of Groningen and PhD from Leiden University. He started his career at ProQR Therapeutics in 2015 and is heading up the chemistry and drug substance manufacturing team within the CMC department at ProQR. In this role he is responsible for the development and optimization of the oligonucleotide manufacturing process and managing all relevant CMC aspects of manufacturing drug substance for clinical use. This includes managing activities at contract manufacturing organizations, product characterization and support regulatory submissions.

Agenda Sessions

  • Switching Gears, From Early Stage Development to Late Stage Validation in 4 Years

    On Demand - Premium Only